Daniel S. Clevenger

Partner - Boston

Bio photo for Daniel Clevenger
Download Media Photo

Contact Information

617.832.1283

617.832.7000

dclevenger@foleyhoag.com Download vCard

Dan Clevenger is a partner in the firm’s business department, where he counsels clients on a wide variety of transactional matters, including public offerings of debt and equity securities, venture capital investments, and mergers and acquisitions. In addition to his transactional work, Dan also has extensive experience advising public companies on compliance with United States federal securities laws, including periodic reporting, proxy solicitations and shareholder communications.

More »

Education:

  • College of William and Mary, J.D., 1999
  • Virginia Tech, B.S. in Biochemistry, 1996

Representative Experience

  • Represented Living Proof, Inc. in its acquisition by Unilever.
  • Represented Applied Genetic Technologies Corporation, a Florida-based biotechnology company, in its initial public offering and subsequent follow-on offering.
  • Represented Hittite Corporation in its sale to Analog Devices, Inc.
  • Represented lead investor in $75 million Series B financing of a pharmaceuticals company.
  • Represented a healthcare information management company and its equity holders in $68.5 million sale to a strategic buyer.
  • Represented Exa Corporation, a Massachusetts-based provider of software simulation tools, in its initial public offering.
  • Represented Art Technology Group, a provider of e-commerce software, in its $1.0 billion sale to Oracle Corporation.
  • Represented lead investor in $55 million investment in development stage biopharmaceutical company.
  • Represented Alere Inc., NYSE-listed medical device manufacturer, in private and public offerings of debt securities with an aggregate principal amount of $1.05 billion.
Add to Bio Folder

Download Bio

Bar Admissions

  • Massachusetts
  • Virginia